For those performing regular resistance training, the target moves higher, to 1.6 to 2.2 grams per kilogram per day
We started with GLP-1s like WEGOVY, have progressed to GLP-1 + GIPR targeting agents like ZEPBOUND, and are nearing entry of GLP-1 + GIPR + Glucagon (Lillys retatrutide)
It is unclear whether the effects on weight are sufficient, by themselves, to enable fibrosis regression
Mounjaro (tirzepatide) is still being studied for long-term effects, but potential risks include gastrointestinal issues (nausea, vomiting, diarrhea, constipation), gallbladder problems (such as gallstones), low blood sugar (if taken with certain diabetes medications), and potential thyroid-related concerns
Is it normal not to lose much (or any) weight in the first week of treatment
When administered by a qualified dermatologist , these injections are safe and have minimal side effects